Literature DB >> 27780742

Association of a TNFSF13B (BAFF) regulatory region single nucleotide polymorphism with response to rituximab in antineutrophil cytoplasmic antibody-associated vasculitis.

Federico Alberici1, Rona M Smith2, Mariana Fonseca2, Lisa C Willcocks2, Rachel B Jones2, Julia U Holle3, Stefan Wieczorek4, Thomas Neumann5, Davide Martorana6, Gina Gregorini7, Renato A Sinico8, Annette Bruchfeld9, Iva Gunnarsson10, Sophie Ohlsson11, Bo Baslund12, Vladimir Tesar13, Zdenka Hruskova13, Maria C Cid14, Augusto Vaglio15, Paul A Lyons2, Kenneth G C Smith2, David R W Jayne2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27780742     DOI: 10.1016/j.jaci.2016.08.051

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  9 in total

Review 1.  Update on ANCA-associated vasculitis: from biomarkers to therapy.

Authors:  Martina Tedesco; Maurizio Gallieni; Francesca Pellegata; Mario Cozzolino; Federico Alberici
Journal:  J Nephrol       Date:  2019-07-12       Impact factor: 3.902

Review 2.  Genetics of ANCA-associated vasculitis: role in pathogenesis, classification and management.

Authors:  Giorgio Trivioli; Ana Marquez; Davide Martorana; Michelangelo Tesi; Andreas Kronbichler; Paul A Lyons; Augusto Vaglio
Journal:  Nat Rev Rheumatol       Date:  2022-09-15       Impact factor: 32.286

3.  The Pharmacogenetics of Rituximab: Potential Implications for Anti-CD20 Therapies in Multiple Sclerosis.

Authors:  Michael Zhong; Anneke van der Walt; Maria Pia Campagna; Jim Stankovich; Helmut Butzkueven; Vilija Jokubaitis
Journal:  Neurotherapeutics       Date:  2020-10-14       Impact factor: 7.620

Review 4.  Gene variants and treatment outcomes in antineutrophil cytoplasmic antibody-associated vasculitis.

Authors:  Arno C Hessels; Jan Stephan F Sanders; Abraham Rutgers; Coen A Stegeman
Journal:  Pharmacogenomics J       Date:  2020-07-18       Impact factor: 3.550

Review 5.  Therapeutic Antibodies: What Have We Learnt from Targeting CD20 and Where Are We Going?

Authors:  Michael J E Marshall; Richard J Stopforth; Mark S Cragg
Journal:  Front Immunol       Date:  2017-10-04       Impact factor: 7.561

Review 6.  Leveraging Genetic Findings for Precision Medicine in Vasculitis.

Authors:  Marialbert Acosta-Herrera; Miguel A González-Gay; Javier Martín; Ana Márquez
Journal:  Front Immunol       Date:  2019-08-02       Impact factor: 7.561

7.  Editorial: "Toward Precision Medicine in Vasculitis".

Authors:  Federico Alberici; Giacomo Emmi; Andreas Kronbichler
Journal:  Front Immunol       Date:  2020-11-17       Impact factor: 7.561

8.  The European Vasculitis Society 2016 Meeting Report.

Authors:  Ingeborg M Bajema; Jan A Bruijn; Alina Casian; Maria C Cid; Elena Csernok; Emma van Daalen; Lorraine Harper; Thomas Hauser; Mark A Little; Raashid A Luqmani; Alfred Mahr; Cristina Ponte; Alan Salama; Mårten Segelmark; Kazuo Suzuki; Jan Sznajd; Y K Onno Teng; Augusto Vaglio; Kerstin Westman; David Jayne
Journal:  Kidney Int Rep       Date:  2017-09-21

Review 9.  Recent advances in understanding of the pathogenesis of ANCA-associated vasculitis.

Authors:  Maria Prendecki; Charles D Pusey
Journal:  F1000Res       Date:  2018-07-19
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.